ICD-10-CM Billable Code

N90.3

Dysplasia of vulva, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Vulvar dysplasia, also referred to as vulvar intraepithelial neoplasia, is a condition characterized by abnormal changes in the skin cells of the vulva, which is the external part of the female genitalia. This condition is considered precancerous because it can potentially develop into vulvar cancer if left untreated. The ICD-10 code N90.3 specifically refers to cases where vulvar dysplasia is diagnosed but the specific type or severity has not been classified.

Causes & Symptoms

Clinical Causes: Human papillomavirus (HPV) infection, particularly high-risk strains Chronic irritation or inflammation of the vulvar skin History of other vulvar conditions or skin disorders Immune system suppression, such as in HIV/AIDS or after organ transplantation Smoking, which can impair immune function and promote HPV persistence Genetic predisposition or family history of vulvar or other gynecologic cancers

Key Symptoms: Persistent itching or irritation in the vulvar area Redness or inflammation of the vulvar skin Thickened, raised, or velvety patches on the vulva White, gray, or pigmented patches that may appear rough or uneven Discomfort or pain during sexual activity or urination Visible lesions or patchy skin changes that do not heal

Diagnostic & Treatment

Diagnosis Path: Diagnosis of vulvar dysplasia generally involves a thorough pelvic examination performed by a healthcare provider. During the examination, visible changes in the vulvar skin may be noted. To confirm the diagnosis, a biopsy of the affected tissue is usually performed, where a small sample is taken and examined under a microscope for abnormal cell changes. Additional testing might include HPV testing to identify high-risk strains associated with the condition. Imaging studies are typically not necessary unless cancer is suspected or to assess the extent of the lesion.

Treatment Protocols: The management of vulvar dysplasia often involves removing the abnormal tissue to prevent progression to cancer. Common treatment options include: - **Surgical excision:** Physically removing the affected skin with or without surrounding margins. - **Laser therapy:** Using focused light energy to destroy abnormal cells. - **Topical medications:** Such as imiquimod or 5-fluorouracil creams that promote immune response or destroy abnormal cells. - **Observation:** In mild cases, close monitoring may be preferred, especially if lesions are small or not causing significant symptoms. Follow-up care is essential to monitor for recurrence or progression. Patients are often advised to avoid irritants like harsh soaps and to maintain good vulvar hygiene. Depending on the individual case, HPV vaccination might be recommended as a preventative measure against future HPV-related lesions.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N90.3 a billable ICD-10 code?
Yes, N90.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N90.3?
Clinical documentation must specify the nature of Dysplasia of vulva, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference